Panax Ginseng 用于 年龄相关认知衰退
C 证据 来自小型研究的证据有限,但存在一些积极信号。Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.
结论
Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.
Key Study Findings
研究人群: None
研究人群: Alzheimer's disease patients (review)
研究人群: None
研究人群: healthy adults
研究人群: None
Key Statistics
15
研究数量
1500
受试者
Mixed
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 200-400 mg/day standardized to 4-7% ginsenosides
上限: Not established; up to 3,000 mg/day used short-term
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
最佳服用时间: Morning; cycling recommended (8 weeks on, 2 weeks off)
Safety & Side Effects
已报告的副作用
- ⚠ Insomnia
- ⚠ Headache
- ⚠ Gastrointestinal discomfort
- ⚠ Changes in blood pressure
- ⚠ Rare: hypoglycemia
已知相互作用
- ● Anticoagulants and antiplatelet drugs
- ● Antidiabetic drugs (may lower blood sugar)
- ● MAO inhibitors (may potentiate effects)
- ● Stimulants (additive stimulatory effects)
可耐受最高摄入量: Not established; up to 3,000 mg/day used short-term
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Panax Ginseng help with 年龄相关认知衰退?
How much Panax Ginseng should I take for 年龄相关认知衰退?
Are there side effects of Panax Ginseng?
How strong is the evidence for Panax Ginseng and 年龄相关认知衰退?
Related Evidence
其他成分用于 年龄相关认知衰退
Panax Ginseng 用于其他健康状况
References
- [1] Rarchita Sharma et al.. Nutr Neurosci. 2025. Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. doi:10.1080/1028415X.2025.2469170 PubMed
- [2] Jingyi Li et al.. Psychopharmacology (Berl). 2025. Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. doi:10.1007/s00213-025-06828-5 PubMed
- [3] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [4] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
- [5] Cindy Crawford et al.. J Altern Complement Med. 2021. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. doi:10.1089/acm.2021.0135 PubMed
- [6] Andrea Brioschi Guevara et al.. Alzheimers Res Ther. 2021. Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. doi:10.1186/s13195-021-00844-1 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。